Pulmonary

Apr 2, 2002

Simplified Practical Chart of Pulmonary
Vascular Segmental Anatomy.

Cote rendition of a practical pulmonary segmental chart to be used for the interpretation of V/Q lung scans.

[Table of Content]

Prostate Imaging

Lutetium-177 PSMA-617 shows promise in earlier-stage prostate cancer

July 21, 2026

GE HealthCare introduces MIM Anyware remote access platform

July 21, 2026

Advancing molecular imaging together

Advancing molecular imaging together

May 24, 2026

Artificial Intelligence Ai 400

Nucs AI, Segmed to build AI validation platform for theranostics

July 14, 2026

Lutetium-177 PSMA-617 shows promise in earlier-stage prostate cancer

Across 14 studies, PSA50 response rates (the number of patients with at least a 50% drop in PSA) ranged from 44% to 100%.

July 21, 2026

Prostate Imaging

GE HealthCare introduces MIM Anyware remote access platform

By AuntMinnie.com staff writers

The platform allows authorized users to access MIM software applications from any location without local installation.

July 21, 2026

AdvanCell raises $315M for targeted alpha therapy

By AuntMinnie.com staff writers

The company is developing ADVC001, a lead-212 (Pb-212)-based targeted alpha therapy for metastatic prostate cancer.

July 15, 2026

Nucs AI, Segmed to build AI validation platform for theranostics

By AuntMinnie.com staff writers

The companies will develop disease-specific registries, curated research cohorts, and validation frameworks.

July 14, 2026

Artificial Intelligence Ai 400

Actineer completes Ra-226 recycling process to support Ac-225 supply

By AuntMinnie.com staff writers

This process aims to improve Ac-225 supply predictability and cost stability, as well as reduce waste generation.

July 14, 2026

Nuclear Medicine Worker Sm

Molecular Partners, Orano Med dose first patients in MP0712 trial

By AuntMinnie.com staff writers

MP0712 is a designed ankyrin repeat protein (DARPin) that targets delta-like ligand 3 (DLL3).

July 2, 2026

Nuclear Medicine

RefleXion Medical submits FDA 510(k) for Anchor Point tumor tracking

By AuntMinnie.com staff writers

RefleXion Medical is seeking FDA clearance for the company's Anchor Point Tracking tech for radiotherapy use.

June 30, 2026

Anchor Point Tracking, designed for use with the new RefleXion X2 platform, underpins SCINTIX therapy with higher fidelity biologic data.

Ratio Therapeutics signs Ac-225 supply agreement with PanTera

By AuntMinnie.com staff writers

Deal will support Ratio's alpha therapy programs.

June 30, 2026

Business Deal Corporate 400

SNMMI mourns passing of Twyla Bartel

By AuntMinnie.com staff writers

The SNMMI is mourning the passing of one of its leading members.

June 23, 2026

Twyla Bartel, DO

AdvanCell establishes U.S. headquarters, manufacturing facility

By AuntMinnie.com staff writers

The Andover site will support development and future commercialization of ADVC001.

June 22, 2026

Nuclearmedicine

New immuno-PET tracer shows promise in prostate cancer

Compared to conventional imaging, Zr-89 DFO-YS5 PET identified additional lesions.

June 15, 2026

A 74-year-old patient with metastatic prostate cancer with a positive left iliac wing lesion (SUVmax of 35.02) seen on (A) Zr-89 DFO-YS5 PET maximum projection image (MIP) and (B) PET/CT (red arrows). The lesion was graded 5 on PET but was not visible on CT (D) or (D) technitium-99 MDP bone scan.

What side effects do patients report after Pluvicto therapy?

Fatigue, pain flare, nausea, and urinary symptoms are among the most commonly reported immediate side effects of Pluvicto therapy.

June 5, 2026

Post-Pluvicto SPECT/CT with axial fused images of sacrum and sagittal maximum intensity projection of one of the patients who complained of increasing pain in the sacral region (arrows) post therapy.

Page 1 of 444